Author

M. T. Bu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

L. Ding· 1 shared L. N. Scott· 1 shared L. SuniD· 1 shared M. G. Lechner· 1 shared M. Su· 1 shared R. M. Prins· 1 shared W. HUGO· 1 shared Y. Zhang· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

L. Ding

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.

L. Ding, L. Sun, M. T. Bu, Y. Zhang, L. N. Scott, R. M. Prins, M. Su, M. G. Lechner, W. HUGO

This study identifies that clonally diverse CXCR5+ B cells enhance IFNγ pathway activity and CD8 T cell responses, leading to durable ICI therapy outcomes in melanoma.

Frontiers in Immunology · Jun 26, 2023Peer-reviewedCancer Biology